Company profile
Alligator Bioscience company profile
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for immunotherapy of cancer. Alligator discovers and develops drug development candidates up to phase IIa clinical studies. Alligator’s pipeline currently counts three immune-modulating projects, ADC-1013, ADC-1015, and ADC-1016. Alligator uses its proprietary technology platforms: ALLIGATOR-GOLD, a unique fully human antibody library, and FIND® (Fragment INduced Diversity), a powerful in vitro based antibody optimization technology, in growing our pipeline.
Business identity
- Contact email
- [email protected]
- Phone number
- 46 4 62 86 42 80
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Revenue range
- $1K+
- Founded
- 2000-01-01
Headquarters
- Headquarters
- Byumba, Northern Province, Rwanda
- Postal code
- 223 81
- Country code
- RW
- Continent
- Africa